VERACYTE, INC. VCYT

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $41.27
Market Cap $3.40B
P/E Ratio 50.33
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑16.0% YoY
$517.14M
3-Yr CAGR: 20.4%
Net Income ↑174.9% YoY
$66.35M
Net Margin: 12.8%
Free Cash Flow ↑98.5% YoY
$126.63M
FCF Yield: 3.73%
EPS (Diluted) ↑164.5% YoY
$0.82
Basic: $0.84
Return on Equity Efficiency
5.1%
ROA: 645.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (VCYT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $65.1M $39.6M $-31.4M $-1.09 $-28.0M $-32.2M
FY 2017 $72.0M +10.6% $43.8M $-31.0M +1.1% $-0.91 +16.5% $-23.9M $-25.7M +20.3%
FY 2018 $92.0M +27.9% $58.9M $-23.0M +25.8% $-0.62 +31.9% $-13.5M $-15.4M +40.0%
FY 2019 $120.4M +30.8% $84.3M $-12.6M +45.2% $-0.27 +56.5% $-3.2M $-6.0M +61.1%
FY 2020 $117.5M -2.4% $75.1M $-34.9M -177.1% $-0.66 -144.4% $-9.7M $-12.5M -109.6%
FY 2021 $219.5M +86.8% $19.4M $-75.6M -116.5% $-1.11 -68.2% $-31.6M $-37.0M -194.8%
FY 2022 $296.5M +35.1% $175.7M $-36.6M +51.6% $-0.51 +54.1% $7.5M $-1.0M +97.3%
FY 2023 $361.1M +21.8% $229.7M $-74.4M -103.5% $-1.02 -100.0% $44.2M $34.3M +3,478.8%
FY 2024 $445.8M +23.5% $126.8M $24.1M +132.4% $0.31 +130.4% $75.1M $63.8M +86.2%
FY 2025 $517.1M +16.0% $168.6M $66.4M +174.9% $0.82 +164.5% $136.3M $126.6M +98.5%
$

Valuation

Market Price $41.27
Market Cap $3.40B
Enterprise Value N/A
P/E Ratio 50.33
P/B Ratio 2.51
FCF Yield 3.73%
Dividend Yield N/A
Shares Outstanding 79,792,600
%

Profitability & Margins

Gross Margin 32.59%
Operating Margin 11.17%
Net Margin 12.83%
Return on Equity (ROE) 5.07%
Return on Assets (ROA) 645.39%
Asset Turnover 50.30x
Revenue 3-Yr CAGR 20.37%
🛡️

Financial Health & Liquidity

Current Ratio 0.21
Cash Ratio 7.43
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $362.58M
Total Debt N/A
Book Value / Share $16.41
💧

Cash Flow Efficiency

Operating Cash Flow $136.31M
Capital Expenditures (CapEx) $9.68M
Free Cash Flow $126.63M
OCF / Revenue 26.36%
FCF / Revenue 24.49%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $0.82
EPS (Basic) $0.84
Dividends / Share N/A
Book Value / Share $16.41
EPS YoY Growth 164.52%
🏛️

Balance Sheet (FY 2025)

Total Assets $10.28M
Total Liabilities $48.80M
Stockholders' Equity $1.31B
Current Assets $10.28M
Current Liabilities $48.80M